ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1987

Elucidation of the Function of Dendritic Cell-Specific Transmembrane Protein (DCSTAMP) in Osteoclast Differentiation

Ananta Paine1, Maria de la Luz Garcia-Hernandez2, Dongge Li3, Minsoo Kim4 and Christopher T. Ritchlin2, 1Department of Medicine, Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 2Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 3Allergy, Immunology and Rheumatology, Division of Allergy/Immunology and Rheumatology and Center for Musculoskeletal Research, School of Medicine and Dentistry, University of Rochester Medical School, Rochester, New York, USA, Rochester, NY, 4Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, New York, USA, Rochester, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bone, RANK/RANKL pathway and osteoclasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Osteoarthritis and Joint Biology – Basic Science Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Osteoclasts (OC) are bone-resorbing, multinuclear cells that originate from myeloid progenitor cells through repetitive cycles of cell-cell fusion. Dendritic cell-specific transmembrane protein (DCSTAMP) is a transmembrane protein essential for cell-cell fusion and formation of fully functional OC although the molecular mechanisms are not well understood. Utilizing RAW cell lines we previously demonstrated that during OC differentiation, heterogeneity in membrane expression levels of DCSTAMP correlated with efficient cell-cell fusion during multinuclear OC formation. Optimal fusion was observed when DCSTAMPlow and DCSTAMPhigh cells interact. Herein, we examined how complete absence of DC-STAMP in the osteogenic progenitor cells (OCPs) controls their ability to participate in cell-cell fusion events required for efficient multinuclear OC formation.

Methods:

We isolated bone marrow macrophages (BMMs) from wild type (WT) and DCSTAMP knockout (KO) mice. DCSTAMP-/- mice show mild osteopetrosis. To analyze cell-cell fusion, we labeled DCSTAMP+/+ and DCSTAMP-/- BMMs obtained from WT and KO mice, respectively, with red (CellVue® Red) and green (CellVue® Jade) membrane dyes, cultured them with MCSF (30 ng/ml) and RANKL (30 ng/ml), and monitored cell-cell fusion with live cell imaging. Moreover, we examined the expression dynamics and fate of DCSTAMP protein in forming OC employing retroviral-mediated expression of GFP-tagged DCSTAMP protein in DCSTAMP-/- cells. In addition, we investigated how DC-STAMP alters expression levels of key osteoclast-related genes in WT and KO cells.

Results:

We find that DCSTAMP-/- BMMs are incorporated into forming OC, however, DCSTAMP+/+ cells are essential to initiate cell-cell fusion events. Following retroviral vector-mediated complementation of GFP-tagged DCSTAMP protein expression in DCSTAMP-/- BMMs, we noted that during OC formation, DC-STAMP expression level remained high but progressively declined during several rounds of cell-cell fusion and levels were low or absent in mature OCs. Interestingly, we noted that the absence of DC-STAMP did not alter mRNA expression levels of NFATc1 and other key genes involved in cell-cell fusion and other OC differentiation pathways such as ACP5, CTSK and ATP6V0D2. Unexpectedly we further noted that mRNA expression levels of ACP5, and CTSK genes were more than 2 fold higher in RANKL activated DC-STAMP-/-cells compared to WT cells after 120 hours in culture.

Conclusion:

Our findings indicate that DCSTAMP expression levels in OCP are high during the early cell-cell fusion events but progressively decline and are absent or low in mature OCs. While DCSTAMP-/- OCPs cannot form multinuclear OCs, they do fuse with DCSTAMP+/+ OCPs and are incorporated into maturing OCs. These data indicate that DCSTAMP membrane expression is not required for cell-cell fusion in the presence of other cells expressing this molecule. The absence of DCSTAMP in OCPs does not alter CTSK, ACP5, ATP6V0D2 mRNA expression levels during early fusion events but these genes were elevated in later stages in KO cells. DC-STAMP may regulate expression of key OC-specific genes in the late stages of OC differentiation.


Disclosure: A. Paine, None; M. D. L. L. Garcia-Hernandez, None; D. Li, None; M. Kim, None; C. T. Ritchlin, AbbVie, Amgen, UCB, 2,AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer Inc, 5.

To cite this abstract in AMA style:

Paine A, Garcia-Hernandez MDLL, Li D, Kim M, Ritchlin CT. Elucidation of the Function of Dendritic Cell-Specific Transmembrane Protein (DCSTAMP) in Osteoclast Differentiation [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/elucidation-of-the-function-of-dendritic-cell-specific-transmembrane-protein-dcstamp-in-osteoclast-differentiation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elucidation-of-the-function-of-dendritic-cell-specific-transmembrane-protein-dcstamp-in-osteoclast-differentiation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology